Literature DB >> 2074043

Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex.

A Comoglio1, G Leonarduzzi, R Carini, D Busolin, H Basaga, E Albano, A Tomasi, G Poli, P Morazzoni, M J Magistretti.   

Abstract

Silybin has been complexed in 1:1 ratio with phosphatidyl choline to give IdB 1016 in order to increase its bioavailability. The antioxidant and free radical scavenger action of this new form of silybin has been evaluated. One hour after the intragastric administration to rats of IdB 1016 (1.5 g/kg b.wt.) the concentration of silybin in the liver microsomes was estimated to be around 2.5 micrograms/mg protein corresponding to a final concentration in the microsomal suspension used of about 10 microM. At these levels IdB decreased by about 40% the lipid peroxidation induced in microsomes by NADPH, CCl4 and cumene hydroperoxide, probably by acting on lipid derived radicals. Spin trapping experiments showed, in fact, that the complexed form of silybin was able to scavenge lipid dienyl radicals generated in the microsomal membranes. In addition, IdB 1016 was also found to interact with free radical intermediates produced during the metabolic activation of carbon tetrachloride and methylhydrazine. These effects indicate IdB 1016 as a potentially protective agent against free radical-mediated toxic damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2074043     DOI: 10.3109/10715769009109673

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  8 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Comparative bioavailability of Silipide, a new flavanolignan complex, in rats.

Authors:  P Morazzoni; M J Magistretti; C Giachetti; G Zanolo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

3.  Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis.

Authors:  Hílton Antônio Mata-Santos; Fabianno Ferreira Dutra; Carolina Carneiro Rocha; Fabiana Gonçalves Lino; Fabiola Ramos Xavier; Leandro Andrade Chinalia; Bryan Hudson Hossy; Morgana Teixeira Lima Castelo-Branco; Anderson Junger Teodoro; Claudia N Paiva; Alexandre dos Santos Pyrrho
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

4.  Comparative pharmacokinetics of silipide and silymarin in rats.

Authors:  P Morazzoni; A Montalbetti; S Malandrino; G Pifferi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jul-Sep       Impact factor: 2.441

5.  Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats.

Authors:  Pragada Rajeswara Rao; Routhu Kasi Viswanath
Journal:  Exp Clin Cardiol       Date:  2007

6.  Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.

Authors:  Pham Quang Vinh; Shigeyuki Sugie; Takuji Tanaka; Akira Hara; Yasuhiro Yamada; Masaki Katayama; Takashi Deguchi; Hideki Mori
Journal:  Jpn J Cancer Res       Date:  2002-01

7.  An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells.

Authors:  G Nishimura; S Yanoma; H Mizuno; K Kawakami; M Tsukuda
Journal:  Jpn J Cancer Res       Date:  1999-11

8.  Botanical agents for the treatment of nonmelanoma skin cancer.

Authors:  Jillian W Millsop; Raja K Sivamani; Nasim Fazel
Journal:  Dermatol Res Pract       Date:  2013-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.